Title: Safety of infliximab and adalimumab in pediatric inflammatory bowel diseases: a
disproportionality analysis from the FAERS database
Version: 1 Date: 17 Jun 2025
Reviewer's report:
Good job.
Title: Safety of infliximab and adalimumab in pediatric inflammatory bowel diseases: a
disproportionality analysis from the FAERS database
Version: 1 Date: 17 Jun 2025
Reviewer's report:
Good job.
Please review this paper.
user
Title: Safety of infliximab and adalimumab in pediatric inflammatory bowel diseases: a
disproportionality analysis from the FAERS database
Version: 1 Date: 17 Jun 2025
Reviewer's report:
Good job.
assistant